Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Tango Therapeutics revenue
Tango Therapeutics's revenue is $42.1 million.
What is Tango Therapeutics's revenue?
- Tango Therapeutics's revenue growth from 2020 to 2024 is 449.49%.
- Tango Therapeutics has 91 employees, and the revenue per employee ratio is $462,296.
- Tango Therapeutics's peak quarterly revenue was $19.9M in 2024(q2).
- Tango Therapeutics peak revenue was $42.1M in 2024.
- Tango Therapeutics annual revenue for 2023 was 36.5M, 46.93% growth from 2022.
- Tango Therapeutics annual revenue for 2024 was 42.1M, 15.17% growth from 2023.
On this page
Zippi applies for you, and finds you a job.
Tango Therapeutics historical revenue
Tango Therapeutics's peak revenue was $42.1M in 2024. The peak quarterly revenue was $19.9M in 2024(q2).
Tango Therapeutics's revenue increased from $7.7m in 2020 to $42.1M currently. That's a 449.49% change in annual revenue.
Tango Therapeutics annual revenue
Tango Therapeutics annual revenue over time
| Fiscal year / year | Tango Therapeutics revenue |
|---|---|
| 2020 | $7.7M |
| 2021 | $37.0M |
| 2022 | $24.9M |
| 2023 | $36.5M |
| 2024 | $42.1M |
How accurately did Tango Therapeutics' revenue projections match actual performance?
Tango Therapeutics annual growth
Tango Therapeutics saw the greatest revenue growth in 2021, when revenue increased by 383.83%.
Tango Therapeutics had the lowest revenue growth in 2022, when revenue changed by -32.89%.
Tango Therapeutics annual growth rate over time
| Year | Tango Therapeutics growth |
|---|---|
| 2021 | 384%↑ |
| 2022 | -33%↓ |
| 2023 | 47%↑ |
| 2024 | 15%↑ |
Tango Therapeutics quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Tango Therapeutics quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2020 | - | - | ($11.3M) | $9.1M |
| 2021 | $6.4M | $18.2M | $6.8M | $5.7M |
| 2022 | $5.8M | $5.8M | $6.9M | $6.4M |
| 2023 | $5.8M | $14.6M | $10.7M | $5.4M |
| 2024 | $6.5M | $19.9M | $11.6M | $4.1M |
Tango Therapeutics jobs nearby
Do you work at Tango Therapeutics?
Is Tango Therapeutics transparent about its revenue structure?
Tango Therapeutics financial information
| CEO | Barbara L. Weber |
| Industry | Pharmaceuticals, Biotechnology & Life Sciences |
| Company Type | Public |
| Employees Number | 91 |
| Date Founded | 2017 |
| Headquarters | Cambridge, Massachusetts |
| Revenue | $42.1M |
| Net Income | -$108,176,000 |
| Tax Rate | -0.0% |
| Total Assets | $436,470,000 |
| Ticker | TNGX |
Tango Therapeutics jobs you might like
Tango Therapeutics financing
Tango Therapeutics received early financing of $55.0M on 2017-03-30.
| Series | Round size | Date |
|---|---|---|
| Series A | $55M | 03/2017 |
| Series B | $60M | 04/2020 |
| Series Unknown | $50M | 08/2020 |
| Post Ipo Equity | $186M | 08/2021 |
Tango Therapeutics investors
| Investors | Security type |
|---|---|
| Third Rock Ventures | Series A |
| Cormorant Asset Management | Series B |
| Boxer Capital | Series B |
| Casdin Capital | Series B |
| Gilead Sciences, Inc. | Series Unknown |
| Cormorant Asset Management | Series Unknown |
| Casdin Capital | Series Unknown |
| Boxer Capital | Series Unknown |
| Logos Capital | Post Ipo Equity |
| EcoR1 Capital, LLC | Post Ipo Equity |
| Woodline Partners LP | Post Ipo Equity |
| Bain Capital Life Sciences | Post Ipo Equity |
| Gilead Sciences, Inc. | Post Ipo Equity |
| AVORO CAPITAL ADVISORS LLC | Post Ipo Equity |
| Fmr | Post Ipo Equity |
| Samsara BioCapital | Post Ipo Equity |
| Farallon Capital Management | Post Ipo Equity |
| Southpoint Capital Advisors | Post Ipo Equity |
| Surveyor Capital | Post Ipo Equity |
| Cormorant Asset Management | Post Ipo Equity |
| Janus Henderson Investors | Post Ipo Equity |
| Foresite Capital | Post Ipo Equity |
| RA Capital Management | Post Ipo Equity |
| Boxer Capital | Post Ipo Equity |
| Casdin Capital | Post Ipo Equity |
Search for jobs
Tango Therapeutics highest paying jobs
Zippia gives an in-depth look into the details of Tango Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Tango Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Tango Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Tango Therapeutics. The data presented on this page does not represent the view of Tango Therapeutics and its employees or that of Zippia.
Tango Therapeutics may also be known as or be related to TANGO THERAPEUTICS, INC., Tango Therapeutics and Tango Therapeutics, Inc.